Company Edwards Lifesciences Corporation
Equities
EW
US28176E1082
Advanced Medical Equipment & Technology
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
92.85 USD | +0.58% | +2.22% | +21.77% |
Business Summary
- hemodynamic monitoring systems (65.4%);
- heart valves and surgery products (18.7%);
- other (15.9%): balloon catheters, artificial implants, etc.
Net sales are distributed geographically as follows: the United States (58.2%), Europe (21.8%), Japan (8.8%) and other (11.2%).
Number of employees: 19,800
Sales per Business
USD in Million | 2022 | Weight | 2023 | Weight | Delta | ||
---|---|---|---|---|---|---|---|
Transcatheter Mitral and Tricuspid Therapies
64.6
%
| 3,518 | 65.4 % | 116 | 2.2 % | 3,880 | 64.6 % | +3,241.77% |
Surgical Heart Valve Therapy
16.6
%
| 893 | 16.6 % | 999 | 16.6 % | +11.89% | ||
Critical Care
15.5
%
| 855 | 15.9 % | 928 | 15.5 % | +8.55% | ||
Transcatheter Mitral and Tricuspid Therapies
3.3
%
| 3,518 | 65.4 % | 116 | 2.2 % | 198 | 3.3 % | +70.20% |
Sales per region
USD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
United States
58.4
%
| 3,133 | 58.2 % | 3,509 | 58.4 % | +12.01% |
Europe
22.2
%
| 1,175 | 21.8 % | 1,335 | 22.2 % | +13.59% |
Rest of World
11.8
%
| 601 | 11.2 % | 709 | 11.8 % | +17.92% |
Japan
7.5
%
| 474 | 8.8 % | 452 | 7.5 % | -4.48% |
Managers
Managers | Title | Age | Since |
---|---|---|---|
Chief Executive Officer | 57 | 14-12-31 | |
Chairman | 71 | 99-12-31 | |
Scott Ullem
DFI | Director of Finance/CFO | 57 | 13-12-31 |
Todd Brinton
CTO | Chief Tech/Sci/R&D Officer | - | 19-01-31 |
Investor Relations Contact | - | - | |
Linda Park
LAW | General Counsel | 46 | - |
Corporate Officer/Principal | 65 | 17-06-30 | |
Tammy Perry
PRN | Corporate Officer/Principal | - | 11-06-30 |
Donald Bobo
PRN | Corporate Officer/Principal | 62 | 94-12-31 |
Gary I. Sorsher
LAW | General Counsel | 59 | 14-12-31 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Leslie Heisz
BRD | Director/Board Member | 63 | 16-07-04 |
Director/Board Member | 67 | 14-11-12 | |
Steven Loranger
BRD | Director/Board Member | 72 | 16-03-15 |
Chairman | 71 | 99-12-31 | |
Paul LaViolette
BRD | Director/Board Member | 66 | 20-07-12 |
Kieran Gallahue
BRD | Director/Board Member | 60 | 15-02-09 |
Martha Marsh
BRD | Director/Board Member | 75 | 15-10-21 |
Ramona Sequeira
BRD | Director/Board Member | 58 | 20-05-06 |
Chief Executive Officer | 57 | 14-12-31 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 650,700,000 | 596,068,856 ( 91.60 %) | 49,400,000 ( 7.592 %) | 91.60 % |
Company contact information
Group companies
Name | Category and Sector |
---|---|
Edwards Lifesciences World Trade Corp.
Edwards Lifesciences World Trade Corp. Medical SpecialtiesHealth Technology Part of Edwards Lifesciences Corp., Edwards Lifesciences World Trade Corp. is an American medical technology company that specializes in the development and manufacturing of heart valves and hemodynamic monitoring. The private company is located in the US. |
Medical Specialties
|
Edwards Lifesciences Technology SARL
| |
Edwards Lifesciences (India) Pvt Ltd.
Edwards Lifesciences (India) Pvt Ltd. Medical SpecialtiesHealth Technology Part of Edwards Lifesciences Corp., Edwards Lifesciences (India) Pvt Ltd. is an Indian company that designs, develops, manufactures and markets products to treat late-stage cardiovascular disease. The private company is based in Mumbai, India. |
Medical Specialties
|
Edwards Lifesciences AG
Edwards Lifesciences AG Medical SpecialtiesHealth Technology Part of Edwards Lifesciences Corp., Edwards Lifesciences AG is a Swiss company that manufactures and distributes healthcare equipment. The private company is based in Nyon, Switzerland. |
Medical Specialties
|
Sector
Sales per Business
Sales per region
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+21.77% | 55.83B | |
+9.28% | 221B | |
+8.70% | 186B | |
+16.38% | 139B | |
+16.31% | 98.65B | |
+5.51% | 67.33B | |
+0.85% | 49.24B | |
+5.08% | 42.81B | |
+17.19% | 41.26B | |
+11.01% | 28.05B |
- Stock
- Equities
- Stock Edwards Lifesciences Corporation - Nyse
- Company Edwards Lifesciences Corporation